Literature DB >> 23126459

Histopathologic staining of low temperature cutaneous burns: comparing biomarkers of epithelial and vascular injury reveals utility of HMGB1 and hematoxylin phloxine saffron.

Douglas A Hirth1, Adam J Singer, Richard A F Clark, Steve A McClain.   

Abstract

Histopathology remains the gold standard for evaluation of burn depth, progression, and healing, but burn literature offers little guidance on the best stains for analysis of these complex and evolving injuries. A battery of histochemical and immunohistochemical stains was compared on adjacent sections to determine the best stains for histopathologic study and imaging of burns. Using a validated porcine model of vertical burn progression, full-thickness cutaneous biopsies were stained using hematoxylin and eosin, Hematoxylin phloxine saffron (HPS), Masson Trichrome, Elastin Von Gieson, Movatt's Pentachrome, vimentin, CD31, KI-67, caspase 3a, and high mobility group box 1. Depth of collagen degeneration, cellular necrosis, apoptosis, and vascular occlusion; and reparative processes of cellular hyperplasia, reepithelialization, and new collagen deposition were measured by ocular microscopy. High mobility group box 1 was superior for necrosis between 1 and 24 hours postburn. Vimentin underestimated necrosis until 48 hours postburn. For overall assessment, hematoxylin and eosin and HPS were comparable, except for analysis of thermally injured collagen, vessel occlusion, erythrocyte extravasation, and polariscopic study of collagen deposition, where HPS was superior. HPS stain offers specific advantages in histopathologic burn analysis. Inexpensive and rapid to produce, HPS allows users to analyze eosinophilic components more precisely than standard hematoxylin and eosin.
© 2012 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23126459     DOI: 10.1111/j.1524-475X.2012.00847.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  8 in total

1.  Burn Injury Alters Epidermal Cholinergic Mediators and Increases HMGB1 and Caspase 3 in Autologous Donor Skin and Burn Margin.

Authors:  Casey J Holmes; Jennifer K Plichta; Richard L Gamelli; Katherine A Radek
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

2.  Endothelial necrosis at 1 hour postburn predicts progression of tissue injury.

Authors:  Douglas Hirth; Steve A McClain; Adam J Singer; Richard A F Clark
Journal:  Wound Repair Regen       Date:  2013-04-29       Impact factor: 3.617

3.  Utility of spatial frequency domain imaging (SFDI) and laser speckle imaging (LSI) to non-invasively diagnose burn depth in a porcine model.

Authors:  David M Burmeister; Adrien Ponticorvo; Bruce Yang; Sandra C Becerra; Bernard Choi; Anthony J Durkin; Robert J Christy
Journal:  Burns       Date:  2015-06-30       Impact factor: 2.744

4.  Efficacy and hazards of 425 nm oral cavity light dosing to inactivate SARS-CoV-2.

Authors:  Max A Stockslager; Jacob F Kocher; Leslee Arwood; Nathan Stasko; Rebecca A McDonald; Mark A Tapsak; David Emerson
Journal:  J Dent       Date:  2022-06-17       Impact factor: 4.991

5.  Alerting the body to tissue injury: The role of alarmins and DAMPs in cutaneous wound healing.

Authors:  Traci A Wilgus
Journal:  Curr Pathobiol Rep       Date:  2018-01-20

6.  Metal chelation attenuates oxidative stress, inflammation, and vertical burn progression in a porcine brass comb burn model.

Authors:  Amina El Ayadi; John R Salsbury; Perenlei Enkhbaatar; David N Herndon; Naseem H Ansari
Journal:  Redox Biol       Date:  2021-06-08       Impact factor: 11.799

7.  An optimized staining technique for the detection of Gram positive and Gram negative bacteria within tissue.

Authors:  Sandra C Becerra; Daniel C Roy; Carlos J Sanchez; Robert J Christy; David M Burmeister
Journal:  BMC Res Notes       Date:  2016-04-12

8.  Development of a Consistent and Reproducible Porcine Scald Burn Model.

Authors:  Christine J Andrews; Margit Kempf; Roy Kimble; Leila Cuttle
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.